Literature DB >> 27014880

Spinal antinflammatory action of Diclofenac.

Alberto Sandri1.   

Abstract

Diclofenac is a non-steroidal antinflammatory drug (NSAID) that finds indication in the treatment of debilitating pathologies characterized by chronic pain sustained by inflammation, such as in rheumatic disease (rheumatoid arthritis or osteoarthritis) or periarthritis, bursitis, tendonitis, myositis and sciatica. Its properties differentiate it from other NSAIDs. In fact, diclofenac's increased effect on spinal nociception and chronic neuro-inflammatory pain may be referred to: 1) its synergistic effects on peroxisome proliferator-activated receptor-γ (PPAR- γ) activation and prostaglandin synthesis inhibition (COX-2 inhibition); 2) its capacity of suppressing neuronal hyperexcitability through the blockage of neuronal K+ channels in a concentration-dependant manner; and 3) its facility to cross the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27014880

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  5 in total

1.  Medial prefrontal cortex diclofenac-induced antinociception is mediated through GPR55, cannabinoid CB1, and mu-opioid receptors of this area and periaqueductal gray.

Authors:  Esmaeal Tamaddonfard; Amir Erfanparast; Reza Salighedar; Sina Tamaddonfard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-10-22       Impact factor: 3.000

2.  Low-dose diclofenac in patients with fragility fractures.

Authors:  Letizia Vannucci; Caterina Fossi; Giorgio Gronchi; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2017-05-30

Review 3.  A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac.

Authors:  Fabiola Atzeni; Ignazio Francesco Masala; Piercarlo Sarzi-Puttini
Journal:  Pain Ther       Date:  2018-06-05

Review 4.  Topical Diclofenac, an Efficacious Treatment for Osteoarthritis: A Narrative Review.

Authors:  Frédérique Bariguian Revel; Marina Fayet; Martina Hagen
Journal:  Rheumatol Ther       Date:  2020-02-21

5.  Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways.

Authors:  Francisco das Chagas Pereira de Andrade; Anderson Nogueira Mendes
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.